Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

The oxidoreductase p66Shc acts as tumor suppressor in BRAFV600E-transformed cells.

Furlan T, Khalid S, Nguyen AV, Günther J, Troppmair J.

Mol Oncol. 2018 Jun;12(6):869-882. doi: 10.1002/1878-0261.12199. Epub 2018 May 5.

2.

Novel Insights into the PKCβ-dependent Regulation of the Oxidoreductase p66Shc.

Haller M, Khalid S, Kremser L, Fresser F, Furlan T, Hermann M, Guenther J, Drasche A, Leitges M, Giorgio M, Baier G, Lindner H, Troppmair J.

J Biol Chem. 2016 Nov 4;291(45):23557-23568. Epub 2016 Sep 13.

3.

Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP.

Hatzl S, Geiger O, Kuepper MK, Caraffini V, Seime T, Furlan T, Nussbaumer E, Wieser R, Pichler M, Scheideler M, Nowek K, Jongen-Lavrencic M, Quehenberger F, Wölfler A, Troppmair J, Sill H, Zebisch A.

Cancer Res. 2016 Jun 15;76(12):3644-54. doi: 10.1158/0008-5472.CAN-15-3049. Epub 2016 Apr 15.

Supplemental Content

Loading ...
Support Center